Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves

Vaccine

Volumn 29, Issue 47, 2011, Pages 8719-8730

  Hägglund, Sara ^a   Hu, Kefei ^a   Vargmar, Karin ^a   Poré, Lesly ^a   Olofson, Ann Sophie ^b   Blodörn, Krister ^a   Anderson, Jenna ^a   Ahooghalandari, Parvin ^a   Pringle, John ^a   Taylor, Geraldine ^c   Valarcher, Jean François ^a,b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Bovine respiratory disease; Bronchiolitis; ISCOM; Respiratory syncytial virus; Vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; ISCOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; BREATHING RATE; CALF (BOVINE); CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HELPER CELL; HUMORAL IMMUNITY; INFECTION PREVENTION; INTERFERON PRODUCTION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM TEMPERATURE; VACCINATION; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; BRONCHIOLITIS; CATTLE; CATTLE DISEASES; DRUG CARRIERS; EUROPE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; ISCOMS; LEUKOCYTES, MONONUCLEAR; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; RESPIRATORY SYSTEM; SEVERITY OF ILLNESS INDEX; VACCINATION; VIRAL VACCINES;

EID: 82455210780     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.146     Document Type: Article

References (60)

1. Valarcher J.F., Taylor G. Bovine respiratory syncytial virus infection. Vet Res 2007, 38(March-April (2)):153-180.
2. Assie S., Seegers H., Makoschey B., Desire-Bousquie L., Bareille N. Exposure to pathogens and incidence of respiratory disease in young bulls on their arrival at fattening operations in France. Vet Rec 2009, 165(August (7)):195-199.
3. Verhoeff J., van Nieuwstadt A.P. BRS virus, PI3 virus and BHV1 infections of young stock on self-contained dairy farms: epidemiological and clinical findings. Vet Rec 1984, 114(March (12)):288-293.
4. Viuff B., Tjornehoj K., Larsen L.E., Rontved C.M., Uttenthal A., Ronsholt L., et al. Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol 2002, 161(December (6)):2195-2207.
5. Viuff B., Uttenthal A., Tegtmeier C., Alexandersen S. Sites of replication of bovine respiratory syncytial virus in naturally infected calves as determined by in situ hybridization. Vet Pathol 1996, 33(July (4)):383-390.
6. Liu L., Lehmkuhl H.D., Kaeberle M.L. Synergistic effects of bovine respiratory syncytial virus and non-cytopathic bovine viral diarrhea virus infection on selected bovine alveolar macrophage functions. Can J Vet Res 1999, 63(January (1)):41-48.
7. Gershwin L.J., Berghaus L.J., Arnold K., Anderson M.L., Corbeil L.B. Immune mechanisms of pathogenetic synergy in concurrent bovine pulmonary infection with Haemophilus somnus and bovine respiratory syncytial virus. Vet Immunol Immunopathol 2005, 107(August (1-2)):119-130.
8. Babiuk L.A., Lawman M.J., Ohmann H.B. Viral-bacterial synergistic interaction in respiratory disease. Adv Virus Res 1988, 35:219-249.
9. Tjornehoj K., Uttenthal A., Viuff B., Larsen L.E., Rontved C., Ronsholt L. An experimental infection model for reproduction of calf pneumonia with bovine respiratory syncytial virus (BRSV) based on one combined exposure of calves. Res Vet Sci 2003, 74(February (1)):55-65.
10. Kimman T.G., Zimmer G.M., Westenbrink F., Mars J., van Leeuwen E. Epidemiological study of bovine respiratory syncytial virus infections in calves: influence of maternal antibodies on the outcome of disease. Vet Rec 1988, 123(July (4)):104-109.
11. Inaba Y., Tanaka Y., Sato K., Omori T., Matumoto M. Bovine respiratory syncytial virus. Studies on an outbreak in Japan, 1968-1969. Jpn J Microbiol 1972, 16(September (5)):373-383.
12. Elvander M. Severe respiratory disease in dairy cows caused by infection with bovine respiratory syncytial virus. Vet Rec 1996, 138(February (5)):101-105.
13. Larsen L.E., Tegtmeier C., Pedersen E. Bovine respiratory syncytial virus (BRSV) pneumonia in beef calf herds despite vaccination. Acta Vet Scand 2001, 42(1):113-121.
14. Valarcher J.F., Schelcher F., Bourhy H. Evolution of bovine respiratory syncytial virus. J Virol 2000, 74(November (22)):10714-10728.
15. Gershwin L.J., Schelegle E.S., Gunther R.A., Anderson M.L., Woolums A.R., Larochelle D.R., et al. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 1998, 16(July (11-12)):1225-1236.
16. Schreiber P., Matheise J.P., Dessy F., Heimann M., Letesson J.J., Coppe P., et al. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. J Vet Med B, Infect Dis Vet Public Health 2000, 47(September (7)):535-550.
17. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969, 89(April (4)):422-434.
18. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375(May (9725)):1545-1555.
19. Fulton R.W., Briggs R.E., Payton M.E., Confer A.W., Saliki J.T., Ridpath J.F., et al. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination. Vaccine 2004, 22(January (5-6)):643-649.
20. Vangeel I., Antonis A.F., Fluess M., Riegler L., Peters A.R., Harmeyer S.S. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV. Vet J 2007, 174(November (3)):627-635.
21. Ellis J.A., Gow S.P., Goji N. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves. J Am Vet Med Assoc 2010, 236(May (9)):991-999.
22. Timsit E., Le Drean E., Maingourd C., Belloc C., Guatteo R., Bareille N., et al. Detection by real-time RT-PCR of a bovine respiratory syncytial virus vaccine in calves vaccinated intranasally. Vet Rec 2009, 165(August (8)):230-233.
23. Stott E.J., Thomas L.H., Taylor G. Development of a potent inactivated vaccine against respiratory syncytial virus infection of calves. 14th World Conference on Diseases of Cattle 1986, 669-673. P.J. Hartigan, M.L. Monaghan (Eds.).
24. Patel J.R., Didlick S.A. Evaluation of efficacy of an inactivated vaccine against bovine respiratory syncytial virus in calves with maternal antibodies. Am J Vet Res 2004, 65:417-421.
25. Mawhinney I.C., Burrows M.R., Straub O.C., Lees P., Higgins A.J., Reid D.S. Protection against bovine respiratory syncytial virus challenge following a single dose of vaccine in young calves with maternal antibody. Vet Rec 2005, 156:139-143.
26. van der Sluijs M.T., Kuhn E.M., Makoschey B. A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody. BMC Vet Res 2010, 6:2.
27. Hägglund S., Hu K.F., Larsen L.E., Hakhverdyan M., Valarcher J.F., Morein B., et al. Bovine respiratory syncytial virus ISCOMs - protection in the presence of maternal antibodies. Vaccine 2004, 23:646-655.
28. Pringle J, Valarcher JF, Hu KF, Blodörn K, Hägglund S. Forced oscillation technique measurements of pulmonary function in calves undergoing experimental BRSV infection. Manuscript. (in preparation).
29. West K., Petrie L., Konoby C., Haines D.M., Cortese V., Ellis J.A. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves. Vaccine 1999, 18(December (9-10)):907-919.
30. Taylor G., Thomas L.H., Wyld S.G., Furze J., Sopp P., Howard C.J. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J Virol 1995, 69(November (11)):6658-6664.
31. Taylor G., Bruce C., Barbet A.F., Wyld S.G., Thomas L.H. DNA vaccination against respiratory syncytial virus in young calves. Vaccine 2005, 23(January (10)):1242-1250.
32. Hakhverdyan M., Hägglund S., Larsen L.E., Belak S. Evaluation of a single-tube fluorogenic RT-PCR assay for detection of bovine respiratory syncytial virus in clinical samples. J Virol Methods 2005, 123(February (2)):195-202.
33. Uttenthal A., Larsen L.E., Philipsen J.S., Tjornehoj K., Viuff B., Nielsen K.H., et al. Antibody dynamics in BRSV-infected Danish dairy herds as determined by isotype-specific immunoglobulins. Vet Microbiol 2000, 76(October (4)):329-341.
34. Taylor G., Stott E.J., Bew M., Fernie B.F., Cote P.J., Collins A.P., et al. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 1984, 52(May (1)):137-142.
35. Taylor G., Thomas L.H., Furze J.M., Cook R.S., Wyld S.G., Lerch R., et al. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions. J Gen Virol 1997, 78(December (12)):3195-3206.
36. Ahmed S.A., Gogal R.M., Walsh J.E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994, 170(April (2)):211-224.
37. Rosbottom A., Guy C.S., Gibney E.H., Smith R.F., Valarcher J.F., Taylor G., et al. Peripheral immune responses in pregnant cattle following Neospora caninum infection. Parasite Immunol 2007, 29(April (4)):219-228.
38. Rotting A.K., Freeman D.E., Constable P.D., Eurell J.A., Wallig M.A. Mucosal distribution of eosinophilic granulocytes within the gastrointestinal tract of horses. Am J Vet Res 2008, 69(July (7)):874-879.
39. Bryson D.G., McFerran J.B., Ball H.J., Neill S.D. Observations on outbreaks of respiratory disease in housed calves - (1) epidemiological, clinical and microbiological findings. Vet Rec 1978, 103(November (22)):485-489.
40. Nagele P. Misuse of standard error of the mean (SEM) when reporting variability of a sample. A critical evaluation of four anaesthesia journals. Br J Anaesth 2003, 90(April (4)):514-516.
41. Ramet M., Korppi M., Hallman M. Pattern recognition receptors and genetic risk for RSV infection: value for clinical decision-making?. Pediatr Pulmonol 2011, 46(February (2)):101-110.
42. Brostrom H., Fahlbrink E., Dubath M.L., Lazary S. Association between equine leucocyte antigens (ELA) and equine sarcoid tumors in the population of Swedish halfbreds and some of their families. Vet Immunol Immunopathol 1988, 19(October (3-4)):215-223.
43. Reinhold P., Macleod D., Lekeux P. Comparative evaluation of impulse oscillometry and a monofrequency forced oscillation technique in clinically healthy calves undergoing bronchochallenges. Res Vet Sci 1996, 61(November (3)):206-213.
44. Antonis A.F., Schrijver R.S., Daus F., Steverink P.J., Stockhofe N., Hensen E.J., et al. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. J Virol 2003, 77(November (22)):12067-12073.
45. Castilow E.M., Varga S.M. Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. Future Virol 2008, 3(5):445-454.
46. Meyer G., Deplanche M., Schelcher F. Human and bovine respiratory syncytial virus vaccine research and development. Comp Immunol Microbiol Infect Dis 2008, 31(March (2-3)):191-225.
47. Chen M., Hu K.F., Rozell B., Orvell C., Morein B., Liljestrom P. Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus. J Immunol 2002, 169(September (6)):3208-3216.
48. Getahun A., Heyman B. Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen. Scand J Immunol 2009, 70(September (3)):277-287.
49. Sandbulte M.R., Roth J.A. T-cell populations responsive to bovine respiratory syncytial virus in seronegative calves. Vet Immunol Immunopathol 2002, 84(January (1-2)):111-123.
50. Crowe J.E. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin Infect Dis 2001, 33(November (10)):1720-1727.
51. Hägglund S, Hu KF, Eléouët JF, Ellencrona K, Lövgren-Bengtsson K, Riffault S, et al. Detailed characterization of ISCOMs against bovine respiratory syncytial virus. Manuscript. (in preparation).
52. Letellier C., Boxus M., Rosar L., Toussaint J.F., Walravens K., Roels S., et al. Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology. Vaccine 2008, 26(September (37)):4840-4848.
53. Riffault S., Meyer G., Deplanche M., Dubuquoy C., Durand G., Soulestin M., et al. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine 2010, 28(May (21)):3722-3734.
54. Hu K.F., Elvander M., Merza M., Akerblom L., Brandenburg A., Morein B. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses. Clin Exp Immunol 1998, 113(August (2)):235-243.
55. Hu K.F., Regner M., Siegrist C.A., Lambert P., Chen M., Bengtsson K.L., et al. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703. FEMS Immunol Med Microbiol 2005, 43(February (2)):269-276.
56. Chase C.C., Hurley D.J., Reber A.J. Neonatal immune development in the calf and its impact on vaccine response. Vet Clin North Am Food Anim Pract 2008, 24(March (1)):87-104.
57. Bastida-Corcuera F.D., Butler J.E., Yahiro S., Corbeil L.B. Differential complement activation by bovine IgG2 allotypes. Vet Immunol Immunopathol 1999, 71(October (2)):115-123.
58. Robson N.C., Donachie A.M., Mowat A.M. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells. Eur J Immunol 2008, 38(May (5)):1238-1246.
59. Estes D.M., Brown W.C. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet Immunol Immunopathol 2002, 90(November (1-2)):1-10.
60. Godding V., Sibille Y., Massion P.P., Delos M., Sibille C., Thurion P., et al. Secretory component production by human bronchial epithelial cells is upregulated by interferon gamma. Eur Respir J 1998, 11(May (5)):1043-1052.